Cargando…

Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure

OBJECTIVE: The antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are multisystem diseases of the small blood vessels. Patients experience irreversible damage and psychological effects from AAV and its treatment. An international collaboration was created to investigate the im...

Descripción completa

Detalles Bibliográficos
Autores principales: Robson, Joanna C, Dawson, Jill, Cronholm, Peter F, Milman, Nataliya, Kellom, Katherine S, Ashdown, Susan, Easley, Ebony, Farrar, John T, Gebhart, Don, Lanier, Georgia, McAlear, Carol A, Peck, Jacqueline, Luqmani, Raashid A, Shea, Judy A, Tomasson, Gunnar, Merkel, Peter A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759851/
https://www.ncbi.nlm.nih.gov/pubmed/29379322
http://dx.doi.org/10.2147/PROM.S144992
_version_ 1783291281662803968
author Robson, Joanna C
Dawson, Jill
Cronholm, Peter F
Milman, Nataliya
Kellom, Katherine S
Ashdown, Susan
Easley, Ebony
Farrar, John T
Gebhart, Don
Lanier, Georgia
McAlear, Carol A
Peck, Jacqueline
Luqmani, Raashid A
Shea, Judy A
Tomasson, Gunnar
Merkel, Peter A
author_facet Robson, Joanna C
Dawson, Jill
Cronholm, Peter F
Milman, Nataliya
Kellom, Katherine S
Ashdown, Susan
Easley, Ebony
Farrar, John T
Gebhart, Don
Lanier, Georgia
McAlear, Carol A
Peck, Jacqueline
Luqmani, Raashid A
Shea, Judy A
Tomasson, Gunnar
Merkel, Peter A
author_sort Robson, Joanna C
collection PubMed
description OBJECTIVE: The antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are multisystem diseases of the small blood vessels. Patients experience irreversible damage and psychological effects from AAV and its treatment. An international collaboration was created to investigate the impact of AAV on health-related quality of life (HRQoL), and develop a disease-specific patient-reported outcome measure to assess outcomes of importance to patients. METHODS: Patients with AAV from the UK, USA, and Canada were interviewed to identify salient aspects of HRQoL affected by AAV. The study was overseen by a steering committee including four patient research partners. Purposive sampling of interviewees ensured representation of a range of disease manifestations and demographics. Inductive analysis was used to identify themes of importance to patients; these were further confirmed by a free-listing exercise in the US. Individual themes were recast into candidate items, which were scrutinized by patients, piloted through cognitive interviews and received a linguistic and translatability evaluation. RESULTS: Fifty interviews, conducted to saturation, with patients from the UK, USA, and Canada, identified 55 individual themes of interest within seven broad domains: general health perceptions, impact on function, psychological perceptions, social perceptions, social contact, social role, and symptoms. Individual themes were constructed into >100 candidate questionnaire items, which were then reduced and refined to 35 candidate items. CONCLUSION: This is the largest international qualitative analysis of HRQoL in AAV to date, and the results have underpinned the development of 35 candidate items for a disease-specific, patient-reported outcome questionnaire.
format Online
Article
Text
id pubmed-5759851
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-57598512018-01-29 Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure Robson, Joanna C Dawson, Jill Cronholm, Peter F Milman, Nataliya Kellom, Katherine S Ashdown, Susan Easley, Ebony Farrar, John T Gebhart, Don Lanier, Georgia McAlear, Carol A Peck, Jacqueline Luqmani, Raashid A Shea, Judy A Tomasson, Gunnar Merkel, Peter A Patient Relat Outcome Meas Original Research OBJECTIVE: The antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are multisystem diseases of the small blood vessels. Patients experience irreversible damage and psychological effects from AAV and its treatment. An international collaboration was created to investigate the impact of AAV on health-related quality of life (HRQoL), and develop a disease-specific patient-reported outcome measure to assess outcomes of importance to patients. METHODS: Patients with AAV from the UK, USA, and Canada were interviewed to identify salient aspects of HRQoL affected by AAV. The study was overseen by a steering committee including four patient research partners. Purposive sampling of interviewees ensured representation of a range of disease manifestations and demographics. Inductive analysis was used to identify themes of importance to patients; these were further confirmed by a free-listing exercise in the US. Individual themes were recast into candidate items, which were scrutinized by patients, piloted through cognitive interviews and received a linguistic and translatability evaluation. RESULTS: Fifty interviews, conducted to saturation, with patients from the UK, USA, and Canada, identified 55 individual themes of interest within seven broad domains: general health perceptions, impact on function, psychological perceptions, social perceptions, social contact, social role, and symptoms. Individual themes were constructed into >100 candidate questionnaire items, which were then reduced and refined to 35 candidate items. CONCLUSION: This is the largest international qualitative analysis of HRQoL in AAV to date, and the results have underpinned the development of 35 candidate items for a disease-specific, patient-reported outcome questionnaire. Dove Medical Press 2018-01-04 /pmc/articles/PMC5759851/ /pubmed/29379322 http://dx.doi.org/10.2147/PROM.S144992 Text en © 2018 Robson et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Robson, Joanna C
Dawson, Jill
Cronholm, Peter F
Milman, Nataliya
Kellom, Katherine S
Ashdown, Susan
Easley, Ebony
Farrar, John T
Gebhart, Don
Lanier, Georgia
McAlear, Carol A
Peck, Jacqueline
Luqmani, Raashid A
Shea, Judy A
Tomasson, Gunnar
Merkel, Peter A
Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
title Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
title_full Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
title_fullStr Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
title_full_unstemmed Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
title_short Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
title_sort health-related quality of life in anca-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759851/
https://www.ncbi.nlm.nih.gov/pubmed/29379322
http://dx.doi.org/10.2147/PROM.S144992
work_keys_str_mv AT robsonjoannac healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure
AT dawsonjill healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure
AT cronholmpeterf healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure
AT milmannataliya healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure
AT kellomkatherines healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure
AT ashdownsusan healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure
AT easleyebony healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure
AT farrarjohnt healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure
AT gebhartdon healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure
AT laniergeorgia healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure
AT mcalearcarola healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure
AT peckjacqueline healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure
AT luqmaniraashida healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure
AT sheajudya healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure
AT tomassongunnar healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure
AT merkelpetera healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure